细胞癌-话题@MedSci

#细胞癌#

1086篇内容 | 2792人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1979238, encodeId=a86019e92389e, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=European Radiology：多参数MRI评估口腔舌鳞状细胞癌的肿瘤浸润深度, objectType=article, longId=220570, objectId=2eb12205e08d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2eb12205e08d, replyNumber=0, likeNumber=57, createdTime=2022-02-17, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2eb12205e08d, moduleTitle=European Radiology：多参数MRI评估口腔舌鳞状细胞癌的肿瘤浸润深度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2eb12205e08d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979312, encodeId=b01619e931253, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Cancers：线场共聚焦光学相干断层扫描提高可疑病变基底细胞癌诊断的准确性和置信度, objectType=article, longId=301743, objectId=486d301e43de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=486d301e43de, replyNumber=0, likeNumber=80, createdTime=2022-07-30, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=486d301e43de, moduleTitle=Cancers：线场共聚焦光学相干断层扫描提高可疑病变基底细胞癌诊断的准确性和置信度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=486d301e43de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979288, encodeId=c6a419e9288f8, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Thorac Cancer：局部晚期可切除食管鳞状细胞癌(ESCC)使用脂质体紫杉醇+铂类方案作为新辅助化疗的疗效和安全性, objectType=article, longId=295185, objectId=293529518574, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=293529518574, replyNumber=0, likeNumber=79, createdTime=2022-08-13, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=293529518574, moduleTitle=Thorac Cancer：局部晚期可切除食管鳞状细胞癌(ESCC)使用脂质体紫杉醇+铂类方案作为新辅助化疗的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=293529518574)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979181, encodeId=2c2119e918192, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Nat Cancer：新辅助治疗药物卡博替尼和纳武单抗治疗局部晚期肝细胞癌, objectType=article, longId=215171, objectId=df392151e1d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df392151e1d8, replyNumber=0, likeNumber=70, createdTime=2022-03-29, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df392151e1d8, moduleTitle=Nat Cancer：新辅助治疗药物卡博替尼和纳武单抗治疗局部晚期肝细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df392151e1d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979323, encodeId=e3e119e93230c, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Clin Cancer Res：Pembrolizumab单药治疗晚期肝细胞癌的效果, objectType=article, longId=724681, objectId=ae69e2468173, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae69e2468173, replyNumber=0, likeNumber=74, createdTime=2022-11-29, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae69e2468173, moduleTitle=Clin Cancer Res：Pembrolizumab单药治疗晚期肝细胞癌的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae69e2468173)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979269, encodeId=cf6a19e926980, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Eur Urol：立体定向放疗和短期派姆单抗治疗寡转移性肾细胞癌的疗效和安全性评估 , objectType=article, longId=293393, objectId=a91729339309, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a91729339309, replyNumber=0, likeNumber=74, createdTime=2022-10-11, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a91729339309, moduleTitle=Eur Urol：立体定向放疗和短期派姆单抗治疗寡转移性肾细胞癌的疗效和安全性评估 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a91729339309)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979310, encodeId=452719e9310a2, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=JEADV:三维组织学与连续切片组织学治疗原发性基底细胞癌的比较, objectType=article, longId=301731, objectId=41cf301e31b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41cf301e31b7, replyNumber=0, likeNumber=58, createdTime=2022-04-10, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41cf301e31b7, moduleTitle=JEADV:三维组织学与连续切片组织学治疗原发性基底细胞癌的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41cf301e31b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979303, encodeId=f25219e9303a0, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Clin Cancer Res：陈明教授团队发现不可手术的食管鳞状细胞癌（ESCC）同步放化疗中使用放疗剂量为50Gy更合适, objectType=article, longId=300448, objectId=e70c30044809, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e70c30044809, replyNumber=0, likeNumber=71, createdTime=2022-08-05, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e70c30044809, moduleTitle=Clin Cancer Res：陈明教授团队发现不可手术的食管鳞状细胞癌（ESCC）同步放化疗中使用放疗剂量为50Gy更合适, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e70c30044809)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979141, encodeId=55df19e91418c, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=2021 ASCO：肝细胞癌领域中国之声, objectType=article, longId=212473, objectId=c86c2124e36d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c86c2124e36d, replyNumber=0, likeNumber=142, createdTime=2021-08-24, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c86c2124e36d, moduleTitle=2021 ASCO：肝细胞癌领域中国之声, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c86c2124e36d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979160, encodeId=770419e916026, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Eur Urol：Nivolumab治疗转移性肾细胞癌的患者的原发性肾肿瘤反应 , objectType=article, longId=213725, objectId=ecda213e25ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ecda213e25ad, replyNumber=0, likeNumber=58, createdTime=2021-12-21, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ecda213e25ad, moduleTitle=Eur Urol：Nivolumab治疗转移性肾细胞癌的患者的原发性肾肿瘤反应 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ecda213e25ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979170, encodeId=9cb319e91704f, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Liver Cancer：不可切除肝细胞癌患者基线肝功能和预后的关系：来自3期临床研究REFLECT患者的分析结果, objectType=article, longId=214329, objectId=ec54214329a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec54214329a3, replyNumber=0, likeNumber=47, createdTime=2021-10-03, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec54214329a3, moduleTitle=Liver Cancer：不可切除肝细胞癌患者基线肝功能和预后的关系：来自3期临床研究REFLECT患者的分析结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec54214329a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979291, encodeId=f20519e929194, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Clin Cancer Res：SD-101联合派姆单抗治疗复发/转移性鳞状细胞癌, objectType=article, longId=295436, objectId=e084295436ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e084295436ca, replyNumber=0, likeNumber=67, createdTime=2022-12-10, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e084295436ca, moduleTitle=Clin Cancer Res：SD-101联合派姆单抗治疗复发/转移性鳞状细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e084295436ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979300, encodeId=8c8319e9300c5, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Liver Cancer：晚期肝细胞癌的更佳一线+二线序贯疗法, objectType=article, longId=299978, objectId=e2a32999e851, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2a32999e851, replyNumber=0, likeNumber=80, createdTime=2022-10-30, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2a32999e851, moduleTitle=Liver Cancer：晚期肝细胞癌的更佳一线+二线序贯疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2a32999e851)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979297, encodeId=fd5c19e92977f, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Oncologist：CheckMate 141亚组分析比较nivolumab（那武利尤单抗）和化疗治疗复发或转移性头颈部鳞状细胞癌（R/M SCCHN）患者的疗效, objectType=article, longId=299383, objectId=8ef92993836d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ef92993836d, replyNumber=0, likeNumber=55, createdTime=2022-10-08, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ef92993836d, moduleTitle=Oncologist：CheckMate 141亚组分析比较nivolumab（那武利尤单抗）和化疗治疗复发或转移性头颈部鳞状细胞癌（R/M SCCHN）患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ef92993836d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979158, encodeId=7fb119e9158a0, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Liver Cancer：卡瑞利珠单抗（Camrelizumab）治疗既往治疗进展的晚期肝细胞癌（HCC）患者的疗效：2期临床研究长期随访结果更新, objectType=article, longId=213622, objectId=76842136220f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76842136220f, replyNumber=0, likeNumber=90, createdTime=2021-12-27, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76842136220f, moduleTitle=Liver Cancer：卡瑞利珠单抗（Camrelizumab）治疗既往治疗进展的晚期肝细胞癌（HCC）患者的疗效：2期临床研究长期随访结果更新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76842136220f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979223, encodeId=6a6d19e92239a, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Nat Genet：食管鳞状细胞癌的突变特征研究, objectType=article, longId=219395, objectId=1cfd2193952c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1cfd2193952c, replyNumber=0, likeNumber=85, createdTime=2022-05-31, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1cfd2193952c, moduleTitle=Nat Genet：食管鳞状细胞癌的突变特征研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1cfd2193952c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979212, encodeId=99d519e9212ec, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Br J Cancer：晚期肝细胞癌患者诊断性活检的可行性分析, objectType=article, longId=218510, objectId=91142185104b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91142185104b, replyNumber=0, likeNumber=70, createdTime=2022-08-23, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91142185104b, moduleTitle=Br J Cancer：晚期肝细胞癌患者诊断性活检的可行性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91142185104b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979154, encodeId=348c19e915400, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=BMC Gastroenterology：自然杀伤细胞活性是肝细胞癌治疗后复发风险的危险因素, objectType=article, longId=213150, objectId=838c21315099, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=838c21315099, replyNumber=0, likeNumber=68, createdTime=2021-12-25, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=838c21315099, moduleTitle=BMC Gastroenterology：自然杀伤细胞活性是肝细胞癌治疗后复发风险的危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=838c21315099)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979208, encodeId=2f6619e920882, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=一文了解基底细胞癌的治疗进展, objectType=article, longId=218020, objectId=81fb21802020, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81fb21802020, replyNumber=0, likeNumber=71, createdTime=2021-10-01, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81fb21802020, moduleTitle=一文了解基底细胞癌的治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81fb21802020)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979159, encodeId=1d1c19e91595b, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Nat Commun：食管鳞状细胞癌中诱导化疗结合根治性放化疗与单独放化疗的疗效比较, objectType=article, longId=213631, objectId=4164213631f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4164213631f5, replyNumber=0, likeNumber=77, createdTime=2022-05-13, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4164213631f5, moduleTitle=Nat Commun：食管鳞状细胞癌中诱导化疗结合根治性放化疗与单独放化疗的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4164213631f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

细胞癌

2020-05-29

qingting (审核中...)

前往app查看评论内容

#细胞癌#

European Radiology：多参数MRI评估口腔舌鳞状细胞癌的肿瘤浸润深度

2022-02-17

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Cancers：线场共聚焦光学相干断层扫描提高可疑病变基底细胞癌诊断的准确性和置信度

2022-07-30

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Thorac Cancer：局部晚期可切除食管鳞状细胞癌(ESCC)使用脂质体紫杉醇+铂类方案作为新辅助化疗的疗效和安全性

2022-08-13

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Nat Cancer：新辅助治疗药物卡博替尼和纳武单抗治疗局部晚期肝细胞癌

2022-03-29

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Clin Cancer Res：Pembrolizumab单药治疗晚期肝细胞癌的效果

2022-11-29

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Eur Urol：立体定向放疗和短期派姆单抗治疗寡转移性肾细胞癌的疗效和安全性评估

2022-10-11

qingting (审核中...)

前往app查看评论内容

#细胞癌#

JEADV:三维组织学与连续切片组织学治疗原发性基底细胞癌的比较

2022-04-10

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Clin Cancer Res：陈明教授团队发现不可手术的食管鳞状细胞癌（ESCC）同步放化疗中使用放疗剂量为50Gy更合适

2022-08-05

qingting (审核中...)

前往app查看评论内容

#细胞癌#

2021 ASCO：肝细胞癌领域中国之声

2021-08-24

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Eur Urol：Nivolumab治疗转移性肾细胞癌的患者的原发性肾肿瘤反应

2021-12-21

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Liver Cancer：不可切除肝细胞癌患者基线肝功能和预后的关系：来自3期临床研究REFLECT患者的分析结果

2021-10-03

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Clin Cancer Res：SD-101联合派姆单抗治疗复发/转移性鳞状细胞癌

2022-12-10

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Liver Cancer：晚期肝细胞癌的更佳一线+二线序贯疗法

2022-10-30

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Oncologist：CheckMate 141亚组分析比较nivolumab（那武利尤单抗）和化疗治疗复发或转移性头颈部鳞状细胞癌（R/M SCCHN）患者的疗效

2022-10-08

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Liver Cancer：卡瑞利珠单抗（Camrelizumab）治疗既往治疗进展的晚期肝细胞癌（HCC）患者的疗效：2期临床研究长期随访结果更新

2021-12-27

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Nat Genet：食管鳞状细胞癌的突变特征研究

2022-05-31

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Br J Cancer：晚期肝细胞癌患者诊断性活检的可行性分析

2022-08-23

qingting (审核中...)

前往app查看评论内容

#细胞癌#

BMC Gastroenterology：自然杀伤细胞活性是肝细胞癌治疗后复发风险的危险因素

2021-12-25

qingting (审核中...)

前往app查看评论内容

#细胞癌#

一文了解基底细胞癌的治疗进展

2021-10-01

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Nat Commun：食管鳞状细胞癌中诱导化疗结合根治性放化疗与单独放化疗的疗效比较

2022-05-13

科室
- - 订阅+
  - 更多科室
工具
服务